Abstract
Due to the importance of nature as a source of new drug candidates, the purpose of this article is to emphasize the marine natural products, which exhibit antitubercular activity, published between January 2000 and May 2016, with 138 quotations to 250 compounds obtained from marine resources. These metabolites are organized by chemical constitution and named as simple alkyl lipids derivatives, aromatics derivatives, peptides, alkaloids, terpenoids, steroids, macrolides, and polycyclic polyketides.
Keywords: Antitubercular, marine natural products, Mycobacterium tuberculosis, marine drugs, antimycobacterial, natural product derivatives.
Current Medicinal Chemistry
Title:Antitubercular Marine Natural Products
Volume: 25 Issue: 20
Author(s): Lishu Wang, Jungfeng Wang, Juan Liu and Yonghong Liu*
Affiliation:
- Key Laboratory of Tropical Marine Bio-resources and Ecology, Guangdong Key Laboratory of Marine Materia Medica, RNAM Center for Marine Microbiology, South China Sea Institute of Oceanology, Chinese Academy of Sciences, Guangzhou 510301,China
Keywords: Antitubercular, marine natural products, Mycobacterium tuberculosis, marine drugs, antimycobacterial, natural product derivatives.
Abstract: Due to the importance of nature as a source of new drug candidates, the purpose of this article is to emphasize the marine natural products, which exhibit antitubercular activity, published between January 2000 and May 2016, with 138 quotations to 250 compounds obtained from marine resources. These metabolites are organized by chemical constitution and named as simple alkyl lipids derivatives, aromatics derivatives, peptides, alkaloids, terpenoids, steroids, macrolides, and polycyclic polyketides.
Export Options
About this article
Cite this article as:
Wang Lishu, Wang Jungfeng, Liu Juan and Liu Yonghong*, Antitubercular Marine Natural Products, Current Medicinal Chemistry 2018; 25 (20) . https://dx.doi.org/10.2174/0929867324666170113120221
DOI https://dx.doi.org/10.2174/0929867324666170113120221 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current and Future Treatment Options in Idiopathic Pulmonary Fibrosis
Inflammation & Allergy - Drug Targets (Discontinued) Cytokine/Antibody Complexes: An Emerging Class of Immunostimulants
Current Pharmaceutical Design Hybolites: Novel Therapeutic Tools for Targeting Hyperstructures in Bacteria
Recent Patents on Anti-Infective Drug Discovery Is tRNA Binding or tRNA Mimicry Mandatory for Translation Factors?
Current Protein & Peptide Science Immunogenicity and Therapeutic Effects of pVAX1-rv1419 DNA from Mycobacterium tuberculosis
Current Gene Therapy Synthesis of 99mTc-Rifabutin: A Potential Tuberculosis Radiodiagnostic Agent
Infectious Disorders - Drug Targets Current and Future Pharmaceutical Therapy for Rheumatoid Arthritis
Current Pharmaceutical Design Vitamin D, Sunlight and Cancer Connection
Anti-Cancer Agents in Medicinal Chemistry Modern Approach to Medical Diagnostics - the Use of Separation Techniques in Microorganisms Detection
Current Medicinal Chemistry New Trends in Development of Antimycobacterial Compounds
Infectious Disorders - Drug Targets Ester of Quinoxaline-7-carboxylate 1,4-di-N-oxide as Apoptosis Inductors in K-562 Cell Line: An in vitro, QSAR and DFT Study
Anti-Cancer Agents in Medicinal Chemistry Synthesis and Antimicrobial Activity of Nitroalkenyl Arenes
Anti-Infective Agents Pulmonary Defence Mechanisms
Current Respiratory Medicine Reviews Lipid Nanoformulations for Oral Delivery of Bioactives: An Overview
Current Drug Therapy Chagas Disease Chemotherapy: What Do We Know So Far?
Current Pharmaceutical Design Editorial [Hot topic: Structure-Based Virtual Screening (Guest Editor: Walter Filgueira De Azevedo Jr.)]
Current Drug Targets Topical Antimicrobials for Burn Wound Infections
Recent Patents on Anti-Infective Drug Discovery Mechanisms of Action and Chemical-Biological Interactions Between Ozone and Body Compartments: A Critical Appraisal of the Different Administration Routes
Current Drug Therapy Developments in Structural Genomics: Protein Purification and Function Interpretation
Current Genomics 3D Modeling of Dengue Virus NS4B and Chikungunya Virus nsP4: Identification of a Common Drug Target and Designing a Single Antiviral Inhibitor
Current Computer-Aided Drug Design